Norman E Sharpless
Overview
Explore the profile of Norman E Sharpless including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
19277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sharpless N, Kerlavage A
Biochim Biophys Acta Rev Cancer
. 2021 May;
1876(1):188573.
PMID: 34052390
Current applications of artificial intelligence (AI), machine learning, and deep learning in cancer research and clinical care are highly diverse-from aiding radiologists in reading medical images to predicting oncoprotein folding...
12.
13.
Prasanna P, Citrin D, Hildesheim J, Ahmed M, Venkatachalam S, Riscuta G, et al.
J Natl Cancer Inst
. 2021 Apr;
113(10):1285-1298.
PMID: 33792717
Cellular senescence is an essential tumor suppressive mechanism that prevents the propagation of oncogenically activated, genetically unstable, and/or damaged cells. Induction of tumor cell senescence is also one of the...
14.
Harvey R, Rassen J, Kabelac C, Turenne W, Leonard S, Klesh R, et al.
JAMA Intern Med
. 2021 Feb;
181(5):672-679.
PMID: 33625463
Importance: Understanding the effect of serum antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for identifying at-risk populations and could have implications for...
15.
Pustavoitau A, Barodka V, Sharpless N, Torrice C, Nyhan D, Berkowitz D, et al.
Exp Gerontol
. 2021 Jan;
144:111217.
PMID: 33402297
No abstract available.
16.
Harvey R, Rassen J, Kabelac C, Turenne W, Leonard S, Klesh R, et al.
medRxiv
. 2020 Dec;
PMID: 33354682
Importance There is limited evidence regarding whether the presence of serum antibodies to SARS-CoV-2 is associated with a decreased risk of future infection. Understanding susceptibility to infection and the role...
17.
Foulkes I, Sharpless N
Cancer Discov
. 2020 Dec;
11(1):23-27.
PMID: 33293334
Cancer Grand Challenges is a unique funding platform that dares global, multidisciplinary teams of researchers to come together, think differently, and tackle some of the toughest challenges in cancer research....
18.
Redfield R, Hahn S, Sharpless N
N Engl J Med
. 2020 Oct;
383(17):1606-1609.
PMID: 33085859
No abstract available.
19.
20.